Immunoglobulin a (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization

Infection and Immunity

Volumn 69, Issue 4, 2001, Pages 2328-2338

  Hodge, L M ^a   Marinaro, M ^a   Jones, H P ^a   McGhee, J R ^a   Kiyono, H ^a   Simecka, J W ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; MONONUCLEAR CELL; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PRIORITY JOURNAL; RAT; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; T LYMPHOCYTE;

ADMINISTRATION, INTRANASAL; ANIMALS; CHOLERA TOXIN; FEMALE; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; INFLAMMATION; LUNG; MICE; MICE, INBRED BALB C; NASAL MUCOSA; ORTHOMYXOVIRIDAE; VACCINES;

EID: 0035085492     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.4.2328-2338.2001     Document Type: Article

References (44)

1. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78
2. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children
3. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus
4. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortment vaccine virus in adult volunteers: Role of local antibody in resistance to infection with vaccine virus
5. Migration of antigen-presenting B cells from peripheral to mucosal lymphoid tissues may induce intestinal antigen specific IgA following parenteral immunization
6. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells
7. A solid phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells
8. Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody
9. Influenza virus vaccination of patients with chronic lung disease
10. Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: Safety, immunogenicity and dose-response
11. Nasal immunization with group B streptococci can induce high levels of specific IgA antibodies in cervicovaginal secretions of mice
12. Induction of antibody responses in the common mucosal immune system by respiratory syncytial virus immunostimulating complexes
13. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts
14. Isolation and fractionation of mononuclear cell populations
15. Epithelial transport of IgA immune complexes
16. Antibody responses after Sendai virus infection and their role in upper and lower respiratory tract disease in rats
17. Cholera toxin as a mucosal adjuvant for respiratory antibody responses in mice
18. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985
19. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4
20. TH1 and TH2: Different patterns of lymphokine secretion lead to different functional properties
21. The mucosal and systemic immune responses of children and adults to live and inactivated influenza A virus vaccines
22. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: A randomized controlled trial
23. Immunogenicity of inactivated influenza vaccine in residential homes for elderly people
24. Murine model for evaluation of protective immunity to influenza virus
25. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines
26. Modulation of airway inflammation by passive transfer of allergen specific Th1 and Th2 cells in a mouse model of asthma
27. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity
28. Passive transfer of local immunity, to influenza virus infection by IgA antibody
29. Similar subclass antibody responses after intranasal immunization with UV-inactivated RSV mixed with cholera toxin or live RSV
30. Preferential transport of IgA and IgA-immune complexes to bile compared with other external secretions
31. Role of serum IgA. Hepatobiliary transport of circulating antigen
32. Mucosal immunity in the genital tract: Prospects for vaccines against sexually transmitted diseases - A review
33. Mucosal immunity of the gastrointestinal tract and oral tolerance
34. Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract
35. Upper respiratory tract is the major site of antibody production in mycoplasmal induced chronic respiratory disease
36. Specific and nonspecific antibody responses in different segments of the respiratory tract in rats infected with Mycoplasma pulmonis
37. Dendritic cells are present in the alveolar region of lungs from specific pathogen-free rats
38. Influenza: Pathogenesis and host defense
39. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein
40. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and beta-galactosidase
41. Mucosal immunization with a subunit respiratory syncytial virus vaccine in mice
42. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site
43. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system